Goldman Sachs
FBIO icon

Goldman Sachs’s Fortress Biotech FBIO Stock Holding History

Goldman Sachs’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-66,667
Closed -$2.63M – 6813
2013
Q4 		$2.63M Hold
66,667
– – ﹤0.01% 3790
2013
Q3 		$7.01M Buy
+66,667
New +$8.17M ﹤0.01% 2596

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Goldman Sachs's FBIO Position: Q2 2026 in Review

Goldman Sachs opened a new position in Fortress Biotech (FBIO) in Q2 2026: 96,358 shares worth $295K. The stake represents ﹤0.01% of the portfolio and ranks #6017 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in FBIO as recently as Q2 2025.

Goldman Sachs first reported a position in FBIO in Q3 2013 and has held it in 39 quarters since. The position peaked at $2.89M in Q3 2013. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Goldman Sachs held 96,358 shares of Fortress Biotech worth $295K as of Q2 2026.
  • Fortress Biotech was a new Goldman Sachs position in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6017 holding.
  • Goldman Sachs first reported a position in Fortress Biotech in Q3 2013 and has held it in 39 quarters since.
  • Goldman Sachs's Fortress Biotech position peaked at $2.89M in Q3 2013.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.